Addressing the Underdiagnosis of Alcohol Use Disorder During and After Pregnancy
Recent research reveals significant gaps in the treatment of alcohol use disorder during pregnancy and postpartum, highlighting urgent needs for improved care and support.
Alcohol use disorder (AUD) remains significantly undertreated among pregnant women and new mothers, posing substantial risks to both parents and infants. Despite the availability of evidence-based treatments, including pharmacotherapy and counseling, their utilization during pregnancy is surprisingly low. This gap is partly due to the lack of clear clinical guidelines, limited data on the safety of AUD medications during pregnancy, and prevalent stigma surrounding substance use in pregnant populations.
Recent research analyzing a comprehensive national medical claims database highlighted troubling trends in treatment patterns. The study compared treatment rates between pregnant women and non-pregnant peers, finding that the proportion receiving alcohol-related medication dropped sharply during pregnancy, with only 0.3% of pregnant women on such treatments by the third trimester, compared to 8% of non-pregnant women. After childbirth, treatment rates increased slightly but remained low.
The findings suggest that pregnancy is not necessarily a window of opportunity for engaging women in AUD treatment, as often assumed, but may instead be associated with treatment discontinuation. These gaps in care during pregnancy and postpartum emphasize the urgent need for improved treatment strategies, better guidelines, and reduced stigma to protect entire families from the dangerous consequences of untreated AUD.
For further details, refer to the study published in Alcohol, Clinical and Experimental Research (2025). Source
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Genetic Factors Underlying Sudden Cardiac Death Elevate Heart Failure Risks in Dilated Cardiomyopathy Patients
A comprehensive Spanish study reveals that genetic mutations linked to sudden cardiac death significantly increase the risk of severe heart failure in patients with dilated cardiomyopathy, emphasizing the importance of early detection and personalized treatment strategies.
Blood-Based Genetic Signature Offers New Hope for Parkinson's Disease Diagnosis
New research unveils a blood-based genetic signature that can distinguish Parkinson's disease from other syndromes, paving the way for earlier and more accurate diagnosis.
Study Reveals Gender Differences in Alcohol's Impact on Decision-Making
Research shows that alcohol impacts decision-making more in males than females, highlighting important gender differences. A new rodent study reveals that alcohol induces riskier choices in males, with potential implications for human behavior and treatment strategies.
Breakthrough in Parkinson's Disease Diagnosis and Therapy Using AI and Optogenetics in Mice
A pioneering study using AI and optogenetics in mice offers new insights into early diagnosis and targeted treatment of Parkinson's disease, marking a significant step toward personalized medicine.